Continuous GHRP-2 infusion synchronized the pulsatile release of GH, TSH, and prolactin in critically ill patients, suggesting these hormones share a common regulatory mechanism that GHRP-2 can reactivate.
3 hormones synchronizedGHRP-2 caused GH, TSH, and prolactin pulses to occur simultaneously — evidence for a shared hypothalamic oscillator
What the researchers found
Continuous GHRP-2 infusion synchronized the pulsatile release of GH, TSH, and prolactin in critically ill patients, revealing a common hypothalamic regulatory mechanism that can be pharmacologically reactivated.
Why it matters
The synchronization finding reveals fundamental neuroendocrine biology — a shared oscillator for three pituitary hormones. Clinically, it means GHRP-2 may restore multiple hormonal axes simultaneously in critical illness.
How the study worked
Clinical trial in prolonged critically ill patients. Continuous GHRP-2 IV infusion with frequent blood sampling (every 10-20 minutes) for GH, TSH, and prolactin. Pulse analysis and cross-correlation performed.
What this study cannot tell us
Intensive sampling protocol limits to small patient numbers. Hormonal synchronization doesn't guarantee clinical benefit. The hypothalamic oscillator hypothesis needs further validation.
How to read the evidence
Moderate evidence from an intensive clinical study with detailed hormonal profiling, providing novel insights but limited by small sample inherent to the intensive methodology.
When this study was published
Published in 1999. The concept of a common hypothalamic pulse generator reactivated by GH secretagogues remains an important area of neuroendocrine research.
The bigger picture
Critical illness suppresses multiple hormone systems simultaneously. Finding that a single peptide can reactivate and synchronize multiple axes suggests a common mechanism of suppression and a unified therapeutic approach.
Questions still open
- Does hormonal synchronization improve clinical outcomes?
- What is the hypothalamic oscillator that GHRP-2 reactivates?
- Can this synchronization be achieved with less invasive GHRP administration?
Common questions
Why do ICU patients lose hormone pulses?
Can one drug fix multiple hormone problems?
Read the original research
Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
European journal of endocrinology, 140(1), 17-22
Citation
Van den Berghe, G; Wouters, P; Bowers, C Y; de Zegher, F; Bouillon, R; Veldhuis, J D. (1999). Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.. European journal of endocrinology, 140(1), 17-22.